心脏手术后高敏肌钙蛋白I与30天死亡率
该国际前瞻性队列研究纳入13862例18岁以上心脏手术患者,术后3-12小时及第1、2、3天检测高敏肌钙蛋白I(URL 26 ng/L),用Cox回归样条分析峰值与30天死亡关系并校正欧洲心脏手术风险评估系统II评分。296例(2.1%)在30天内死亡。孤立冠状动脉旁路移植或主动脉瓣置换/修复患者中,术后1天内与校正HR>1.00相关的肌钙蛋白阈值为5670 ng/L(95%CI 1045-8260),即218倍URL;其他心脏手术患者为12981 ng/L(95%CI 2673-16591),即499倍URL。结论认为这些阈值远高于现行定义临床重要围术期心肌损伤的推荐水平。
要点
- 孤立CABG或主动脉瓣置换/修复患者术后1天内高敏肌钙蛋白I阈值5670 ng/L(95%CI 1045-8260,218倍URL)与30天死亡校正HR>1.00相关。
- 其他心脏手术患者相应阈值为12981 ng/L(95%CI 2673-16591,499倍URL)。
- 全队列13862例中296例(2.1%)于术后30天内死亡。
- 现行共识推荐定义围术期心肌梗死/临床重要围术期心肌损伤的阈值为>10倍至≥70倍URL,本研究提示与死亡风险相关的水平远高于此。
- 检测时间点为术后3-12小时及术后第1、2、3天,高敏肌钙蛋白I URL为26 ng/L。
适用人群与场景
- 18岁及以上接受心脏手术的患者,国际前瞻性队列。
- 亚组分析包括孤立冠状动脉旁路移植或主动脉瓣置换/修复患者,以及其他心脏手术患者。
诊断标准与关键阈值
- 高敏肌钙蛋白I检测上限参考值(URL)为26 ng/L。
- 检测时间:术后3-12小时及术后第1、2、3天。
- 与30天死亡风险相关的阈值:孤立CABG或主动脉瓣置换/修复患者为5670 ng/L(95%CI 1045-8260,218倍URL);其他心脏手术患者为12981 ng/L(95%CI 2673-16591,499倍URL)。
研究设计与关键结果
- 国际前瞻性队列研究纳入13862例患者,296例(2.1%)在术后30天内死亡。
- 采用Cox回归样条分析峰值肌钙蛋白与30天死亡关系,校正欧洲心脏手术风险评估系统II评分。
- 孤立CABG或主动脉瓣置换/修复患者中,术后1天内与校正HR>1.00相关的肌钙蛋白阈值为5670 ng/L(95%CI 1045-8260),即218倍URL。
- 其他心脏手术患者相应阈值为12981 ng/L(95%CI 2673-16591),即499倍URL。
证据类型、等级与局限
- 研究类型:国际前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论认为,心脏术后与30天死亡风险增加相关的高敏肌钙蛋白I水平显著高于现行定义临床重要围术期心肌损伤的推荐水平(>10倍至≥70倍URL)。
指南或共识出处
- 资金来源:加拿大健康研究院(Canadian Institutes of Health Research)等;临床试验注册号NCT01842568。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Consensus recommendations regarding the threshold levels of cardiac troponin elevations for the definition of perioperative myocardial infarction and clinically important periprocedural myocardial injury in patients undergoing cardiac surgery range widely (from >10 times to ≥70 times the upper reference limit for the assay). Limited evidence is available to support these recommendations.
METHODS: We undertook an international prospective cohort study involving patients 18 years of age or older who underwent cardiac surgery. High-sensitivity cardiac troponin I measurements (upper reference limit, 26 ng per liter) were obtained 3 to 12 hours after surgery and on days 1, 2, and 3 after surgery. We performed Cox analyses using a regression spline that explored the relationship between peak troponin measurements and 30-day mortality, adjusting for scores on the European System for Cardiac Operative Risk Evaluation II (which estimates the risk of death after cardiac surgery on the basis of 18 variables, including age and sex).
RESULTS: Of 13,862 patients included in the study, 296 (2.1%) died within 30 days after surgery. Among patients who underwent isolated coronary-artery bypass grafting or aortic-valve replacement or repair, the threshold troponin level, measured within 1 day after surgery, that was associated with an adjusted hazard ratio of more than 1.00 for death within 30 days was 5670 ng per liter (95% confidence interval [CI], 1045 to 8260), a level 218 times the upper reference limit. Among patients who underwent other cardiac surgery, the corresponding threshold troponin level was 12,981 ng per liter (95% CI, 2673 to 16,591), a level 499 times the upper reference limit.
CONCLUSIONS: The levels of high-sensitivity troponin I after cardiac surgery that were associated with an increased risk of death within 30 days were substantially higher than levels currently recommended to define clinically important periprocedural myocardial injury. (Funded by the Canadian Institutes of Health Research and others; VISION Cardiac Surgery ClinicalTrials.gov number, NCT01842568.).
参考来源
- Devereaux PJ, Lamy A, Chan MTV, et al. High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality. N Engl J Med. 2022. PMID: 35235725. doi:10.1056/NEJMoa2000803
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。